CURC treatment was also found to downregulate AQP1 in rat choroid plexus cells, useful to reduce cerebrospinal fluid production in some pathophysiological conditions [60], and AQP3 expression in human ovarian cancer cells [61]. This evidence concerns the gene AQP3 and ovarian cancer.